|
RBMS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.168940E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07629996423964E-09 |
| Normal-vs-Stage2 |
2.875000E-01 |
| Normal-vs-Stage3 |
1.693800E-01 |
| Normal-vs-Stage4 |
8.642600E-01 |
| Stage1-vs-Stage2 |
4.076900E-03 |
| Stage1-vs-Stage3 |
2.861499999951E-06 |
| Stage1-vs-Stage4 |
1.04439999981665E-08 |
| Stage2-vs-Stage3 |
8.940200E-01 |
| Stage2-vs-Stage4 |
2.467800E-01 |
| Stage3-vs-Stage4 |
1.453420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.571240E-04 |
| Normal-vs-AfricanAmerican |
8.798400E-02 |
| Normal-vs-Asian |
1.635170E-01 |
| Caucasian-vs-AfricanAmerican |
6.944800E-01 |
| Caucasian-vs-Asian |
2.187800E-01 |
| AfricanAmerican-vs-Asian |
2.796400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.767900E-04 |
| Normal-vs-Female |
3.166900E-04 |
| Male-vs-Female |
6.395200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.901700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.52096999999074E-05 |
| Normal-vs-Age(61-80Yrs) |
9.055600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.049000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.771400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.591000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.298600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.857980E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.480040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.549600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.391890E-04 |
| Normal-vs-Grade 2 |
2.38099995275576E-09 |
| Normal-vs-Grade 3 |
4.671500E-02 |
| Normal-vs-Grade 4 |
1.070210E-01 |
| Grade 1-vs-Grade 2 |
4.140300E-03 |
| Grade 1-vs-Grade 3 |
4.81430000309757E-08 |
| Grade 1-vs-Grade 4 |
4.52670001482858E-09 |
| Grade 2-vs-Grade 3 |
8.88370000007299E-07 |
| Grade 2-vs-Grade 4 |
2.61640042964473E-10 |
| Grade 3-vs-Grade 4 |
1.837720E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.4491519923231E-13 |
| Normal-vs-ccB subtype |
7.450800E-01 |
| ccA subtype-vs-ccB subtype |
3.00870439673417E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.678500E-03 |
| Normal-vs-N1 |
6.332400E-01 |
| N0-vs-N1 |
1.067020E-01 |
|
|
